Arpit Jain

Helex is taking the promise of non-viral targeted delivery and genome editing to the kidney, developing first-in-class genetic medicines for renal indications. Helex combines its proprietary kidney tropic lipid nanoparticle delivery system with the Epic-Cure(TM) 3D genome-based drug designer platform to create a robust renal franchise of precise and scalable therapeutics. Our lead asset is a mutation-agnostic, potential one-and-done therapy for Autosomal Dominant Polycystic Kidney Disease that impacts over 4 million people worldwide.

Founded on a mother’s love and necessity, Mishmash Naturals emerged when our founder, Kanika, sought a safe alternative for her daughter allergic to adult makeup. This led to Mishmash, Indias first Ayurvedic makeup brand for kids. Committed to safety and quality, we offer age-appropriate products crafted with natural ingredients sourced from Ayurvedic traditions. Mishmash is not just a makeup brand; it celebrates childhood, ensuring every product is safe, natural, and imbued with the essence of motherly care. Our formulations are organic and meticulously curated to uphold the highest standards of purity and effectiveness. Join us in our journey to redefine children’s imagination in makeup with products that are gentle and effective, rooted in the principles of Ayurveda, and crafted with unwavering love and dedication.

Qweebi is an early-stage EdTech startup headquartered in Singapore and backed by Antler Venture Capital. Were making hands-on, experiential learning accessible to all! We’re building the worlds first online experiential learning platform that enables K-6 educators to teach Science/STEM through virtual hands-on interactive projects, instead of boring class lectures. We enable students to apply STEM, critical thinking, creativity to solve real-world problems in Physical, Earth, and Life Sciences. We’re a team of passionate game developers, software engineers, product designers, and marketers with a collective experience of 20+ years to develop fun and engaging games and build multi-million dollar businesses from the ground up.

Byonyks has engineered an FDA-cleared state-of-the-art peritoneal dialysis machine, transforming care for patients with kidney failure. Globally, over eight million people with kidney disease lack dialysis access—a costly, invasive, and time-consuming treatment that filters blood when kidneys fail. Many of these individuals face life-threatening consequences due to the lack of proper care. Byonyks addresses this critical issue with its Bloodless Dialysis machine, a safe, effective, portable, and non-invasive solution that’s more affordable than existing options. Our technology empowers patients to perform dialysis at home, overnight, while they sleep, allowing them to maintain their daily work and family responsibilities. The needle-free approach also reduces the risk of chronic infections such as HIV and Hepatitis C. Headquartered in Chicago, Byonyks is a medical device startup founded by Harvard & MIT graduates and industry experts. Our core team’s expertise contributes to over half of the operational peritoneal dialysis machines in the USA. The machine has saved multiple lives in South Asia and is currently under review by the FDA—a pivotal step towards making accessible kidney care a global reality.

A global live-learning edtech platform for kids from 6 to 16 years to learn next-gen life skills such as Coding, Financial Literacy, Communication Skills and Robotics. BrightCHAMPS is currently valued at $650 million with a $63 million investment, and services 30+ countries (India, Indonesia, US, UAE, Vietnam, and many other countries across SEA and MENA) in 12+ languages across its 4 verticals. It is our vision and mission to become the world’s most learning impact-driven educational organisation by empowering the world’s 2 billion kids with next-gen life skills to help level the playing field for success, regardless of gender, physical, socio-political, cultural and financial considerations.

KidExs vision is to catapult Indias positioning in terms of GDP per capita by making every young Indian an income generating member of society. For the same, every young Indian should have the right skills for their desired domain of career interest. KidEx has created a unique, globally first, AI powered platform to help young Indians (college students as well as K12 students) gain Experiential Learning across multiple dimensions beyond academics in an asynchronous manner. The company runs two businesses: masterNAUKRI (mN) & Young All Rounder (YAR). masterNAUKRI by KidEx (www.masternaukri.com) is a platform for companies & colleges. Companies can hire full time/internship roles related freshers at zero cost while minimizing the number of interviews. Students skill videos help the company easily decide if the candidate is worth their interviewing bandwidth or not. YAR by KidEx is a mobile-first platform for K12 School students aged 5 to 18 years to gain exposure to Real-Life Skills Beyond Academics through Experiential Learning. Majority of top B Schools in India have reported that students lack holistic profile & mindset which pre-dominantly gets developed during the early years of a childs life (5 to 18 years). Our platform has been awarded & recognized by leading organizations like Google, MEITY, Yourstory, TiE. Our platform is used by leading organizations like IIMs, Private MBA Schools (NIRF Top 100), CSR Foundations, Leading Govt. Bodies etc.

Helex is taking the promise of non-viral targeted delivery and genome editing to the kidney, developing first-in-class genetic medicines for renal indications. Helex combines its proprietary kidney tropic lipid nanoparticle delivery system with the Epic-Cure(TM) 3D genome-based drug designer platform to create a robust renal franchise of precise and scalable therapeutics. Our lead asset is a mutation-agnostic, potential one-and-done therapy for Autosomal Dominant Polycystic Kidney Disease that impacts over 4 million people worldwide.

Founded on a mother’s love and necessity, Mishmash Naturals emerged when our founder, Kanika, sought a safe alternative for her daughter allergic to adult makeup. This led to Mishmash, Indias first Ayurvedic makeup brand for kids. Committed to safety and quality, we offer age-appropriate products crafted with natural ingredients sourced from Ayurvedic traditions. Mishmash is not just a makeup brand; it celebrates childhood, ensuring every product is safe, natural, and imbued with the essence of motherly care. Our formulations are organic and meticulously curated to uphold the highest standards of purity and effectiveness. Join us in our journey to redefine children’s imagination in makeup with products that are gentle and effective, rooted in the principles of Ayurveda, and crafted with unwavering love and dedication.

Qweebi is an early-stage EdTech startup headquartered in Singapore and backed by Antler Venture Capital. Were making hands-on, experiential learning accessible to all! We’re building the worlds first online experiential learning platform that enables K-6 educators to teach Science/STEM through virtual hands-on interactive projects, instead of boring class lectures. We enable students to apply STEM, critical thinking, creativity to solve real-world problems in Physical, Earth, and Life Sciences. We’re a team of passionate game developers, software engineers, product designers, and marketers with a collective experience of 20+ years to develop fun and engaging games and build multi-million dollar businesses from the ground up.

Byonyks has engineered an FDA-cleared state-of-the-art peritoneal dialysis machine, transforming care for patients with kidney failure. Globally, over eight million people with kidney disease lack dialysis access—a costly, invasive, and time-consuming treatment that filters blood when kidneys fail. Many of these individuals face life-threatening consequences due to the lack of proper care. Byonyks addresses this critical issue with its Bloodless Dialysis machine, a safe, effective, portable, and non-invasive solution that’s more affordable than existing options. Our technology empowers patients to perform dialysis at home, overnight, while they sleep, allowing them to maintain their daily work and family responsibilities. The needle-free approach also reduces the risk of chronic infections such as HIV and Hepatitis C. Headquartered in Chicago, Byonyks is a medical device startup founded by Harvard & MIT graduates and industry experts. Our core team’s expertise contributes to over half of the operational peritoneal dialysis machines in the USA. The machine has saved multiple lives in South Asia and is currently under review by the FDA—a pivotal step towards making accessible kidney care a global reality.

A global live-learning edtech platform for kids from 6 to 16 years to learn next-gen life skills such as Coding, Financial Literacy, Communication Skills and Robotics. BrightCHAMPS is currently valued at $650 million with a $63 million investment, and services 30+ countries (India, Indonesia, US, UAE, Vietnam, and many other countries across SEA and MENA) in 12+ languages across its 4 verticals. It is our vision and mission to become the world’s most learning impact-driven educational organisation by empowering the world’s 2 billion kids with next-gen life skills to help level the playing field for success, regardless of gender, physical, socio-political, cultural and financial considerations.